Soonmee Cha, MD

University of California
San Francisco

Identification of Prognostic Surrogate Markers in Malignant Gliomas by Quantitative Magnetic Resonance Imaging

Charles Conrad, MD and
Jeremy Rich, MD

MD Anderson
Cancer Center
and
Duke University

Development of Potential Synergistic Therapies with Small Molecule Inhibitors of Receptor Tyrosine Kinases, Intracellular Signal Transduction Elements and Cytotoxic Therapies

John Fiveash, MD

University of Alabama
at Birmingham

Enhancement of Glioma Radiation Therapy and Chemotherapy Response with Targeted Antibody Therapy Against Death Receptor 5

Eric Holland, MD, PhD

Memorial Sloan-Kettering Cancer Center

Proteomic Serum Marker for Gliomas

Paul Mischel, MD

University of California
Los Angeles

Pathway Profiling of Glioblastoma:  Identification of Molecular Correlates of Sensitivity to EGFR Inhibitors

Charles Sawyers, MD

University of California
Los Angeles

Identification of Activated Kinases in Glioblastoma Multiforme

WK Alfred Yung, MD

MD Anderson
Cancer Center

Novel PTEN/PI3K Pathway Inhibitors for Glioblastoma Therapy